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Abstract: Multi-ingredient pre-workout supplements are a popular class of dietary supplements
which are purported to improve exercise performance. However, the composition of these products
varies substantially between formulations, thus making comparisons challenging. Therefore,
the purpose of this study was to identify a common ingredient profile of top-selling pre-workout
supplements and to compare ingredient dosages to established efficacious values. The top 100
commercially available pre-workout products were analyzed for listed ingredients and amounts,
if available, from the supplement facts panel. The mean ± SD number of ingredients per supplement
(n = 100) was 18.4 ± 9.7 with 8.1 ± 9.9 of these ingredients included in a proprietary blend at
undisclosed quantities. Relative prevalence and average amounts of the top ingredients amounted to:
Beta-alanine (87%; 2.0 ± 0.8 g), Caffeine (86%; 254.0 ± 79.5 mg), Citrulline (71%; 4.0 ± 2.5 g), Tyrosine
(63%; 348.0 ± 305.7 mg), Taurine (51%; 1.3 ± 0.6 g), and Creatine (49%; 2.1 ± 1.0 g). Nearly half
(44.3%) of all ingredients were included as part of a proprietary blend with undisclosed amounts of
each ingredient. The average amount of beta-alanine per serving size was below the recommended
efficacious dose. The average caffeine content was near the low end for an effective relative dose for a
70 kg individual (3–6 mg·kg−1 of bodyweight).
Keywords: ergogenic aid; supplement; pre-workout; beta-alanine; caffeine; citrulline; creatine;
strength; power; energy

1. Introduction
Dietary supplements represent approximately a 30-billion-dollar industry in the United States
alone [1], with over 50% of US adults reporting the regular use of one or more supplements [2]. In 1994,
Congress passed the Dietary Supplement Health and Education Act, which established an official
definition for a dietary supplement, stating that in order for a product to be classified as a dietary
supplement it must meet one or more of the following: (1) A vitamin, (2) A mineral, (3) A herb or
other botanical, (4) An amino acid, (5) A dietary substance for use by man to supplement the diet by
increasing the total dietary intake, or (6) A concentrate, metabolite, constituent, or extract of one of the
above categories [3]. Dietary supplement manufacturers have a lot of liberty in how they design and
formulate their products. Currently, there is not a pre-market approval process needed to document
the efficacy and safety before new dietary ingredients can be included into a manufactured dietary
supplement product, as long as they meet the aforementioned criteria. However, the Food and Drug
Administration (FDA) does require a pre-market notification of a new dietary ingredient (NDI) to
be submitted by the manufacturer at least 75 days prior to marketing the NDI in a supplement [4].
Additionally, the FDA has strict guidelines for supplement facts panel labeling in regards to what
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ingredients are required to be listed on the label and how they are presented [5], in an attempt to
provide the consumer with adequate information regarding the ingredients included in the dietary
supplement. Otherwise, dietary supplement manufacturers are able to formulate products at their
own discretion which leads to variable ingredient profiles across the market.
Multi-ingredient pre-workout supplements (MIPS) are a specialized category of dietary
supplements intended to be consumed prior to exercise that include a blend of ingredients purported
to increase exercise performance [6]. A recent 2018 review found MIPS ingestion led to acute ergogenic
benefits following a single dose while subsequently augmenting training adaptations when routinely
ingested over time in conjunction with a training program [7]. The authors also found minimal reports
of adverse events following continued supplementation. MIPS often contain a proprietary blend or
matrix formula in an attempt to maintain a level of confidentiality with product formulations [8].
The FDA only mandates that the total weight of the ingredients included in the blend are listed but the
individual ingredients amounts themselves do not need to be disclosed [5]. However, the ingredients
need to be listed in a descending order of predominance by weight and followed by a symbol specifying
that the daily values of such ingredients are not established [5]. Unfortunately, this does not provide
the consumer with adequate information to determine whether an effective dose of each ingredient is
included in the product or to ensure safety if they are also consuming other related dietary supplement
products. For example, if an individual consumes a MIPS in addition to a multivitamin, an energy shot,
or other caffeinated beverage, they could be unknowingly at risk of ingesting high levels of ingredients
such as caffeine or niacin that could result in adverse events.
A variety of factors likely influence manufacturer decisions when it comes to product development
of MIPS, such as physiological rationale for structure and function claims, clinically supported evidence
of efficacy, cost efficiency, raw ingredient availability, patents of formulations, and taste or texture.
There does appear to be a common core list of ingredients commonly found in MIPS, including
caffeine, beta-alanine, creatine, citrulline, taurine, tyrosine, and B vitamins; however, not all products
contain the same core ingredients, making it difficult to compare one product to another [7]. Further,
MIPS are sometimes confused with energy drinks, energy shots, blood flow enhancers, or weight
loss supplements as they can contain similar ingredients. Although there is some overlap of certain
ingredients, the purported benefits and mechanisms of action of the respective products are different
and tend to include different complimentary ingredients [9–11]. For example, MIPS tend to contain
ingredients that are purported to improve acute exercise performance in addition to enhancing training
adaptations over time such as caffeine, beta-alanine, creatine, and betaine. Conversely, energy shots
and energy drinks generally only contain caffeine and a select number of vitamins or amino acids
that are more targeted at increasing energy or levels of alertness and can be ingested at any time
throughout the day. Furthermore, they tend to lack any additional ingredients that influence muscular
performance or adaptations. Currently, there is not a well-established list of criteria that classifies a
supplement as a MIPS, nor is there an accepted common ingredient profile of such a product. Therefore,
the focus of the current study was to examine supplement facts panels of the top selling commercially
available MIPS within the US to characterize common ingredient profiles to help establish a standard
definition of a MIPS product. A secondary aim of the study was to compare the mean ingredient
profile of commonly identified ingredients (if disclosed) and to evidence-based recommendations
regarding an efficacious dose.
2. Materials and Methods
The top 100 commercially available MIPS were identified and compiled from a commercial retail
website (www.bodybuilding.com) as of October 2018. Independent sales data were not available, so
the included MIPS products were identified after filtering the searched products using a “best-selling”
criteria as previously used by Desbrow and colleagues [12]. For the purpose of this study, a MIPS
product must have met the following criteria to be classified as a pre-workout supplement and included
in the analysis: (A) Marketed as a pre-workout supplement; (B) Recommended to be ingested prior
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to exercise; and containing at least three of the following ingredients: (1) Caffeine, (2) Beta-alanine,
(3) Citrulline, (4) Niacin, (5) Creatine, (6) Taurine, (7) Tyrosine, (8) Arginine, (9) Branched chain amino
acids, (10) Choline Bitartrate, or (11) Betaine. These criteria were used to create distinction between
MIPS and other similar products that may be marketed as a pre-workout supplement but are more
similar to strictly blood flow enhancers or energy shots. Two research staff members independently
analyzed each supplement facts label to compile listed ingredients and corresponding amounts,
if available, for each product. Special notation was used for ingredients that were listed on the product
label as part of a propriety blend and therefore specific ingredient amounts were not available. Only
ingredients included in the nutrition facts and supplement facts sections of the label were included.
Thus, ingredients listed as “other ingredients”, such as preservatives, artificial flavoring agents, and
food coloring, were not included in the analysis. Because the information used for analysis is publicly
available, approval from an Institutional Review Board was not required.
Statistical Analysis
All data are presented as means ± SD. Basic descriptive and frequency analysis was performed for
the included ingredients across each product to create a common MIPS ingredient profile. Means and
standard deviations were reported for each ingredient explicitly listed on the supplement facts label.
Frequency analysis was used to determine the relative prevalence of listed and unlisted ingredients
within the dataset as well as the prevalence of supplements included in the analysis which contained
an ergogenic amount of key ingredients. Linear regression analysis was employed to determine the
relationship between the included amount of key ingredients and total serving size of each supplement.
Correlation coefficients were interpreted as weak (r ≤ 0.35), moderate (0.36 ≤ r ≤ 0.67), or strong
(0.68 ≤ r ≤ 0.99) [13]. An alpha level of 0.05 was used for all statistical determinations.
3. Results
3.1. Ingredient and Proprietary Blends
The mean ± SD number of ingredients per pre-workout supplement (n = 100) was 18.4 ± 9.7 with
8.1 ± 9.9 of these ingredients included in a proprietary blend at undisclosed quantities. The percentage
of total ingredients included in a proprietary blend for all 100 supplements was 44.3%. In addition,
58/100 supplements included at least one proprietary blend with 14.0 ± 9.2 ingredients, or 63.8 ± 24.4%
of all ingredients, at undisclosed quantities.
3.2. Specific Ingredients
Table 1 provides the prevalence (%) of specific ingredients included in the 100 pre-workout
supplements for both undisclosed and listed amounts, the mean ± SD quantities of ingredients that
were listed on the label, the suggested ergogenic quantity of each ingredient, and the prevalence (%) of
supplements that contained each ingredient at this suggested ergogenic level.
Table 1. Prevalence and quantities of ingredients included in the bestselling pre-workout supplements
(n = 100). MIPS: Multi-ingredient pre-workout supplements.
Ingredient

Overall
Prevalence
(%)

Prevalence in
Undisclosed
Quantity (%)

Prevalence in
Listed
Quantity (%)

Mean ± SD
Listed
Quantity

Suggested
Ergogenic
Quantity

Prevalence (%) of
MIPS ≥ Ergogenic
Quantity

Beta-Alanine (g)
Caffeine (mg)
Citrulline (g)
Tyrosine (mg)
Taurine (g)
Creatine (g)
Niacin (mg)
Arginine (g)
Vitamin B12 (µg)

87
86
71
63
51
49
48
46
45

30
15
23
31
22
18
0
21
0

57
71
48
32
29
31
48
25
45

2.0 ± 0.8
254.0 ± 79.5
4.0 ± 2.5
348.0 ± 305.7
1.3 ± 0.6
2.1 ± 1.0
25.8 ± 15.2
1.3 ± 0.7
121.7 ± 227.2

4.0
210.0
6.0

1 (1.8%)
44 (77.2%)
18 (37.5%)

3.0

9 (29.0%)

3.0

1 (4.0%)
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Listed45
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(%)
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13 6
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11
8
8
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17
18
11
11
10
3

25
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18
11
11
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3

Suggested
Mean ± SD
121.7 ± 227.2
Ergogenic
Listed
Quantity
1.9 ± 0.8 Quantity

Prevalence (%) of
MIPS ≥ Ergogenic
Quantity

1.9 376.5
± 0.8 ± 243.0
376.5 ±
243.0± 83.9
121.6
121.6 ± 3.2
83.9± 1.9
3.2 ± 1.9
686.4 ± 634.4
686.4 ± 634.4
19.2 ±19.2
11.6± 11.6
400.5 ±
173.2± 173.2
400.5
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The
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significant
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were significant
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< 0.001,
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across
serving
size (Figure
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however,
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0.14,
size
(Figure
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were no1).
significant
relationships,
however,
for creatine
(r = 0.14,
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p
=
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n
=
31)
or
arginine
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=
0.30,
p
=
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n
=
24)
versus
serving
size
(Figure
1).
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Figure 1. The relationships for beta-alanine (n = 56), caffeine (n = 70), citrulline (n = 47), creatine
Figure 1. The relationships for beta-alanine (n = 56), caffeine (n = 70), citrulline (n = 47), creatine (n =
(n = 31), arginine (n = 24), and number of ingredients (n = 94) versus serving size for the pre-workout
31), arginine (n = 24), and number of ingredients (n = 94) versus serving size for the pre-workout
supplements. Dashed line represents the minimum suggested ergogenic quantity.
supplements. Dashed line represents the minimum suggested ergogenic quantity.

4. Discussion
The purpose of this investigation was to determine a typical ingredient profile of best-selling
MIPS products by establishing a standard definition of a MIPS used to identify such products in the
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4. Discussion
The purpose of this investigation was to determine a typical ingredient profile of best-selling MIPS
products by establishing a standard definition of a MIPS used to identify such products in the analysis
and to determine the prevalence of best-selling MIPS formulations containing efficacious doses of
well-supported ergogenic ingredients. Based upon the results of the current evaluation, the most
popular MIPS ingredients appear to be beta-alanine, caffeine, citrulline, tyrosine, taurine, creatine,
and niacin, as each of these ingredients appeared in at least 48% of the top 100 selling MIPS products
(Table 1). Average listed amounts and overall relative prevalence of these ingredients in the sample
amounted to the following: Beta-alanine (prevalence: 87%; average listed amount: 2.0 ± 0.8 g), Caffeine
(prevalence: 86%; average listed amount: 254.0 ± 79.5 mg), Citrulline (prevalence: 71%; average listed
amount: 4.0 ± 2.5 g), Tyrosine (prevalence: 63%; average listed amount: 348.0 ± 305.7 mg), Taurine
(prevalence: 51%, average listed amount: 1.3 ± 0.6 g), Creatine (prevalence: 49%, average listed
amount: 2.1 ± 1.0 g), and Niacin (prevalence: 48%, average listed amount: 25.8 ± 15.2 mg). These
results are somewhat similar to the conclusions of Eudy and colleagues [8], who identified caffeine,
creatine, beta-alanine, and taurine as typical ingredients in pre-workout supplements in a 2013 review.
However, the researchers classified several common energy drinks as pre-workout supplements, thus
skewing the typical ingredient profile of the included products. It is important to note that the average
listed caffeine content of the products included in the current investigation (254.0 ± 79.5 mg) was
in accordance with the findings of a previous study by Desbrow et al. [12], which investigated the
caffeine content in top selling MIPS products in Australia and found average caffeine content per
serving to be 100–390 mg. Interestingly, the authors noted a high degree of variation between the
caffeine dose presented on the label and the actual caffeine content of a given product as determined
by high performance liquid chromatography. There was also a degree of variability from one batch
to another.
It is worth noting that the average amounts of certain ingredients do not appear to align with
the clinically-supported dosing recommendations for beta-alanine [14], caffeine [15], citrulline [16],
creatine [17], or arginine [18], as depicted in Figure 1. Because pre-workout supplements provide a
variety of ingredients to the consumer in a single formulation, it is vital that ingredients be included at
efficacious doses as this ultimately determines the long-term ergogenic potential. However, the high
prevalence of proprietary blends in this sample limited the assessment of dosing efficacy to ingredients
with explicit amounts listed on a given supplement facts label. Nonetheless, the analysis of listed
ingredient amounts provides valuable information regarding the potential of the well-supported
ergogenic ingredients included in these supplements to confer any substantial benefit. For example,
the average creatine content of the included MIPS products was 2.1 ± 1.0 g, which is below the
minimum dose of at least 3 g·day−1 and the standard recommended daily dose of 5 g·day−1 that
has been supported within the literature [17]. Furthermore, only 29% of MIPS products in this
investigation listed creatine in amounts greater than or equal to the minimum ergogenic quantity.
Similarly, the average listed beta-alanine content was 2.0 ± 0.8 g, which is also below the minimum
ergogenic dose of 4 g·day−1 [14]. Interestingly, while the amount of beta-alanine was listed in 57
of the included products, only one of these products contained a dose greater than the threshold
of efficacy. Clearly, consumers using these products who wish to increase intramuscular carnosine
levels and subsequently improve intramuscular buffering capacity will need to consume beta-alanine
from other supplemental sources. In contrast to several of the earlier ingredients, the average caffeine
content of the included MIPS was 254 ± 7.5 mg, which is above the 210 mg required to meet the lower
threshold for a recommended dose (3–6 mg·kg−1 of bodyweight) reported within the literature [15].
However, this recommendation is based on a 3 mg·kg−1 dose for a 70 kg individual. Thus, while 77.2%
of the included formulations contained more than 210 mg of caffeine, these formulations may not
confer ergogenic effects in individuals with a body weight greater than 70 kg, which may often be
the case as MIPS products are typically marketed towards individuals engaged in resistance training
or bodybuilding practices who are likely larger than 70 kg. Additionally, it is important to note that
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because most MIPS products are marketed towards this population and previous reviews [19–21]
indicate that a caffeine intake closer to 6 mg·kg−1 of bodyweight is likely needed to elicit an ergogenic
benefit during resistance exercise, the average caffeine content in MIPS may also be insufficient for
those consuming them for strength or power-related benefits. Because the minimum suggested doses
for several of these ingredients were rarely met, it is clear that many MIPS formulations are inadequate
sources of ergogenic ingredients, such as beta-alanine, citrulline, and creatine, and may not deliver
enough caffeine to provide performance benefits in larger individuals.
The high prevalence of proprietary blends within the sample (58% of all MIPS products) has
significant implications for consumers, as each proprietary blend contained 14.0 ± 9.2 ingredients
(63.8 ± 24.4% of all listed ingredients) on average. As mentioned previously, while FDA regulations
mandate that all ingredients in a blend be listed in descending order of predominance by weight,
it is difficult to determine whether individual ingredients in a proprietary blend are included in
doses sufficient to elicit ergogenic effects [7]. However, the results of this study suggest total serving
size of a given MIPS product may serve as a potential indicator of supplement efficacy, as several
ingredients in the sample were shown to be positively correlated with serving size (Figure 1). For
example, moderate to high correlations were found between total MIPS sample size and the following
ingredients: caffeine (r = 0.44, p < 0.001, n = 70), beta-alanine (r = 0.49, p < 0.001, n = 56), and citrulline
(r = 0.73, p < 0.001, n = 47). However, no significant relationships were found between total supplement
serving size and creatine or arginine. Though the relationship between serving size and amount of
key ingredients could only be determined in open-label products, serving size may also serve as a key
metric when evaluating the efficacy of MIPS products with a high percentage of ingredients contained
in a proprietary blend. For example, a MIPS with a serving size of 8 g will not contain both the 6 g
minimum ergogenic dose of citrulline [16] and the 4 g minimum dose of beta-alanine [14]. Thus, we
recommend that supplement consumers consider total serving size when making purchasing decisions,
as products with a larger serving size likely contain greater doses of several key ergogenic ingredients.
A concerning trend identified by this investigation was the average listed vitamin B3 (niacin)
content in the included products (25.8 ± 15.2 mg), which approached the tolerable upper intake
level (UL) of 35 mg·day−1 [22]. To date, several investigations have linked the consumption of
niacin-containing energy products with acute hepatitis [23,24] and liver failure [25] in otherwise-healthy
adults. Though niacin content was explicitly listed on all MIPS which contained it as an ingredient,
it is possible that consumers may not fully understand the potential hazard of consuming multiple
servings of MIPS or combining MIPS with other niacin-containing products such as energy shots
or energy drinks [10]. Similarly, consuming multiple servings of MIPS or combining MIPS with
other caffeine-containing substances may place consumers at risk of adverse events resulting from
excess caffeine consumption, including tachycardia, heart palpitations, headache, anxiety, and sleep
disturbance [26,27]. However, the average caffeine content in the included MIPS products was found
to be 254 ± 79.5 mg, which is well below the 400 mg·day−1 (6 mg·kg−1 ) threshold of consumption
suggested by Nawrot and colleagues [28] in a seminal review. Thus, provided that MIPS consumers
keep daily niacin and caffeine intake within acceptable limits, the risk of adverse events resulting from
these substances will likely be mitigated.
A limitation of this investigation is that presented values are based off the provided supplement
facts panel from the manufacturer and may not reflect actual ingredient amounts contained within
the product as it is off the shelf. As highlighted by Desbrow et al. [12], select ingredient amounts may
vary from batch to batch or within a single batch and may not reflect posted ingredient amounts on
the provided supplement facts label. Therefore, results of this study should be interpreted within
the appropriate context of profiling supplement ingredients from supplement facts labels and not
laboratory-based methods of assessing actual ingredients contained in these products.
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5. Conclusions
By establishing a common ingredient profile and more standard definition of a MIPS, future
research can now better investigate the efficacy, and more importantly, the safety of these products by
creating a level of distinction between MIPS and other related products. The findings of the present
investigation indicated that beta-alanine and citrulline are the most common ingredients found in
multi-ingredient pre-workout supplements. The average amount of beta-alanine per serving size
falls well below the recommended efficacious dose. The average dose of caffeine is near the low
end of an effective relative dose (3–6 mg·kg−1 of bodyweight) for a 70 kg individual at 3.6 mg·kg−1
of bodyweight. Additionally, nearly half of the ingredients in MIPS are manufactured as part of a
proprietary blend with undisclosed amounts of each ingredient. It may be in the best interest of the
consumer to select a MIPS product that discloses all ingredient amounts and contains appropriate
dosages of each ingredient. Consumers may also want to pay close attention to specific ingredients
that may be under-dosed (beta-alanine and creatine in particular), as they may want to supplement
with other products in order to optimize the associated benefits. Further, it is advisable to reduce
ingestion of other caffeine or niacin containing products to minimize the risk of any adverse events
from consuming excess amounts. Future research should examine how individuals are utilizing these
products, particularly if they are being combined with other related products, in an attempt to identify
any safety concerns. Additionally, more information is needed regarding the purity and quality of
MIPS products, specifically ones that contain proprietary blends, so that individuals know exactly
what they are consuming with each serving.
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